The Latest
-
Profile
Surgeries are moving to ASCs. Distalmotion wants its robot to drive the shift.
CEO Greg Roche says ambulatory surgery centers have largely lacked access to robots for performing soft tissue procedures, until now.
-
Health disparities persist across states and may widen further with federal cuts: report
Native, Hispanic and Black communities experienced worse health access and affordability issues than white people in most states, according to a new report from the Commonwealth Fund.
-
Profit recovery is ‘priority No. 1,’ Humana promises
Humana’s foremost priority is returning to 3% Medicare Advantage margins in 2028, CEO Jim Rechtin repeatedly promised investors on Wednesday morning. Still, the insurer’s profits dipped in the first quarter.
-
UHS reaffirms 2026 volume targets, despite seasonal hits in Q1
A weaker-than-expected respiratory season paired with winter storms caused UHS’ volumes to decline in the first quarter. Executives said they expect growth in the second half will help the operator meet earnings targets this year.
-
Frequency of medical liability lawsuits is declining, but risk remains for doctors: AMA
The risk of being sued is higher among certain specialties like surgeons, and increases the longer doctors practice medicine, according to the medical association's new report.
Updated April 29, 2026 -
Centene hikes 2026 profit guidance after buoyant Q1
The insurer, a mainstay in government programs like Medicaid and the ACA exchanges that have been wracked by higher spending, successfully controlled costs in the quarter, leading to $1.5 billion in profit.
-
Profile
With ultrasound on a chip, Butterfly Network aims for global reach
Butterfly, which makes handheld imaging machines, hopes to make the technology accessible to more patients with its pricing and AI features.
-
Insurers making progress on standardizing prior authorizations
Aligning electronic data submission requirements for prior authorizations is one prong of the insurance industry’s commitment to reform the unpopular preapprovals.
-
CFOs feel healthcare pain rising as GLP-1s stretch budgets: Mercer
Average healthcare costs for U.S. employers are expected to rise 6.7% this year, hitting a 15-year high.
-
ACA subsidy lapse cost HCA Healthcare $150M in Q1
The hit was in line with HCA’s expectations. The hospital operator is the first of its peers to detail financial impacts from the expiration of more generous subsidies in Affordable Care Act plans.
-
Medicare AI prior authorization pilot delaying care in Washington: report
The report compiled by Sen. Maria Cantwell, D-Wash., found procedures in the state that were previously approved in two weeks now take four to eight weeks to be authorized.
Updated April 27, 2026 -
FTC, US Anesthesia Partners reach settlement in Texas price collusion case
The private equity-backed anesthesia provider bought and bullied its way to market dominance in Texas, driving up prices for patients, the FTC alleged. The parties have now reached a deal, though USAP will not admit liability.
-
Molina controls costs in Q1 but future Medicaid spending in doubt
The insurer beat analyst expectations for adjusted earnings in the first quarter. But steeper Medicaid membership losses than expected could saddle Molina with higher costs down the line.
-
CMS, FDA unveil speedier Medicare coverage pathway for breakthrough devices
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.
-
AMA urges lawmakers to implement safeguards on AI chatbots
Though chatbots could have some benefits for mental health access, the physician lobby argued “immediate attention is required” to avoid harming patients looking for support.
-
Flagging first-quarter volumes dragged CHS’ earnings
Executives said consumer fears and aggressive denials from payers fueled declining volumes in the quarter, leading CHS to a $58 million loss. Still, the hospital operator expects volumes to pick up in the back half of the year.
-
Elevance perks up in 2026 though Medicare Advantage payout could ding profits
The Indianapolis-based insurer raised its 2026 earnings guidance after posting a better first quarter than Wall Street expected. Still, Elevance lodged a $935 million expense to cover what it might owe the CMS over faulty data reporting.
Updated April 22, 2026 -
Prices rose after No Surprises arbitration for some care: analysis
The data compiled by the Brookings Center on Health Policy shows that average arbitration prices for some services like imaging were seven times higher than Medicare prices.
-
Amazon One Medical launches weight management program including GLP-1 drugs
The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing support care and transparent pricing on prescriptions.
-
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
-
UnitedHealth hikes profit outlook after better-than-expected first quarter
Premium hikes, plan redesigns and other efforts from the Minnesota-based company to wrangle medical spending bore fruit in the first quarter. UnitedHealth’s stock jumped accordingly.
-
Providers push back on 340B rebate model
Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.
-
Blue Shield of California taps chief pharmacy officer
Hayley Park will oversee BSCA’s prescription drug programs. The insurer has worked to overhaul its pharmacy management model in a bid to lower drug costs.
-
Retrieved from QuikTrip.
QuikTrip to sell urgent care clinics after 6 years in business
The retailer, which at one point had 14 MedWise sites, is divesting its nine-location network to Saint Francis Health System.
-
RFK Jr. defends HHS tenure, 12% proposed budget cut
Republicans largely praised the HHS secretary’s track record during a marathon of House hearings last week, but some GOP lawmakers raised concerns about proposed budget cuts to the National Institutes of Health.